Identification and antifungal susceptibility of candida isolates from various clinical specimens in doctor Behçet uz hospital

Anatolian Journal of Clinical Investigation

Volumn 3, Issue 3, 2009, Pages 170-173

  Tulumoǧlu, Şener ^a   Kariptaş, Ergin ^b   Erdem, Belgin ^b  

^a Behçet Uz Education and Research Hospital   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PICHIA ANOMALA; SPECIES COMPARISON; SPECIES DISTRIBUTION;

EID: 77952892793     PISSN: 13068814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N: Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses 50:52, 2006.
2. Berry V, Badyal DK: Sensitivity of clinical isolates of Candida species to antifungal drugs. J Med Education Res 8:214, 2006.
3. Mohanty S, Xess I, Hasan F, Kapil A, Mittal S, Tolosa JE: Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis. Indian J Med Res 126:216, 2007.
4. Eraso E, Ruesga M, Villar-Vidal M, Carrillo-Muñoz AJ, Espinel-Ingroff A, Quindós G: Comparative evaluation of ATB Fungus 2 and Sensititre Yeast One panels for testing in vitro Candida antifungal susceptibility. Rev Iberoam Micol 25:3, 2008.
5. Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol. Rev 20(1):133, 2007.
6. Forbes BA, Sahm DF, Weissfeld AS: Bailey and Scott's Diagnostic Microbiology. 11th ed. Missouri, Mosby; 2002.
7. Kantarcioǧlu AS, Yücel A: Epidemiology of deep mycoses; considerations on antifungal prophylaxis and antifungal susceptibility tests. Cerrahpaşa J. Med 32(3): 184, 2001.
8. Gültekin, B Aydin, N: Klinik örneklerden izole edilen Candida türlerinin daǧilimi ve tani yöntemlerinin deǧ erlendirilmesi. İnfeks Derg 18(2): 229, 2004.
9. Pina-Vaz, C, Costa-de-Oliveira, S, Tavares, C, Rodrigues, AG: Susceptibility of clinical yeasts from sterile sites to fluconazole and voriconazole. TIMM-Amsterdam: 2003 [cited 2008 May 5]. Available from: http://www.ecmm.org/TIMM2003.pdf. p135.
10. Adiloǧlu A, Şirin CM, Aridoǧan-Cicioǧlu B, Can R: Identification and antifungal susceptibilities of Candida Species isolated from various clinical specimens. Adnan Menderes Ünv. Tip Fak. Derg 5(3):33, 2004.
11. Çitak S, Özçelik B, Cesur S, Abbasoǧlu U: In vitro susceptibility of Candida isolated from blood culture to some antifungal agents. Jpn. J. Infect. Dis. 58:44, 2005.
12. Kaya K, Kaya S, Avunduk H, Özyazici G, Bakici MZ: The distribution of species and antifungal susceptibilities of agents of candiduria over a ten months period at Cumhuriyet University Hospital. C. Ü. Tip Fak. Der 26(2):71, 2004.
13. Deǧerli K, Ecemiş T, Özkütük N, Özbakkaloǧlu B, Sürücüoǧlu S: İnvazif infeksiyon olan Candida kökenlerinde antifungal direncin incelenmesi. Turkish J of Infection; 21(2):224, 2007.